腹腔镜肝门部胆管癌切除术治疗进展  

Progress in treatment of laparoscopic resection for hilar cholangiocarcinoma

作　　者：丁剑毅 张宇华[2] 黄东胜[2] Ding Jianyi;Zhang Yuhua;Huang Dongsheng(Second Clinical Medical College,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Hepatobiliary and Pancreatic and Minimally Invasive Surgery,Zhejiang Provincial People's Hospital,Hangzhou 310014,China)

机构地区：[1]浙江中医药大学第二临床医学院,杭州310053 [2]浙江省人民医院肝胆胰和微创外科,杭州310014

出　　处：《中华肝胆外科杂志》2020年第11期870-873,共4页Chinese Journal of Hepatobiliary Surgery

摘　　要：肝门部胆管癌(HCCA)是一种预后极差的胆道恶性肿瘤,术前影像学目前对其分期的准确性较低,根治性手术切除是唯一可能的治愈选择。腹腔镜技术在HCCA治疗中的应用还处于探索阶段,其手术安全性、根治性尚有很多争议。本文回顾性分析了腹腔镜下HCCA切除术的研究现状。Hilar cholangiocarcinoma(HCCA)is a malignant tumor of the biliary tract with dismal prognosis.However the preoperative imaging has limited value to evaluate the clinical stage,and radical resection remains the only potential curative option for these patients.The application of laparoscopic technique in HCCA is still in the preliminary stage with very few reports due to controversies on its safety and oncological adequacy.In this paper,we summarized the current status of laparoscopic resection for hilar cholangiocarcinoma in order to provide theoretical basis for the decision-making in clinical practice.

关 键 词：Klatskin肿瘤 腹腔镜 治疗 

分 类 号：R735.8[医药卫生—肿瘤]